1887
Volume 2025, Issue 3
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

The study was conducted to determine the impact of the COVID-19 pandemic on the incidence and stage of breast cancer in different age groups.

This retrospective study analyzed changes in the epidemiological and clinical structure of the cohort of patients treated in the radiotherapy department of the Bydgoszcz Oncology Centre in Poland from 2016 to 2023.

The results of the study showed that in the group of patients under 39 years of age, an increase in the incidence rate was recorded in 2020, and a decrease in 2021 to 2023. A decrease in the incidence rate was also observed in the group of patients aged 40 to 49 years in the period 2021 to 2022 and in the groups 50 to 59, 60 to 69, and >80, from 2020 to 2023. An increase in the incidence rate was recorded in the group of patients aged 70 to 79 years in 2020, 2022, and 2023, and a decrease was observed in 2021. In the group of patients under 40 years of age, the impact of the pandemic on reducing the number of cases of stage I cancer was recorded in 2020, 2022, 2023, stage IIa—in 2020, stage IIIa—from 2020 to 2023, stage IIIb—in 2020. Instead, in 2020, the number of cases of stage IIb and stage IIIc breast cancer increased, and the rate of stage IV cancer detection increased significantly, which remained high throughout the pandemic. In the group of patients over 40 years of age, a decrease in the detection rate of stage I cancer was observed from 2020 to 2023, and stage IIa in 2020. An increase in stage IIIa cancer detection was recorded in 2020, stage IIIb in 2021 to 2023, and a significant increase in stage IV detection from 2020 to 2023.

The results demonstrated that the COVID-19 pandemic has become one of the important factors in the delayed diagnosis of breast cancer.

© 2025 Huda, Yasir, Mughal, Arif, licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2025.85
2025-09-15
2026-03-07

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/qmj/2025/3/qmj.2025.85.html?itemId=/content/journals/10.5339/qmj.2025.85&mimeType=html&fmt=ahah

References

  1. Guthmuller S, Carrieri V, Wübker A. Effects of organized screening programs on breast cancer screening, incidence, and mortality in Europe. J Health Econ. 2023 12; 92:102803.https://doi.org/10.1016/j.jhealeco.2023.102803
     [Google Scholar]
  2. Lofters AK, Wu F, Frymire E, Kiran T, Vahabi M, Green ME, et al.. Cancer screening disparities before and after the COVID-19 pandemic. JAMA Netw Open. 2023 11; 6:(11):e2343796.https://doi.org/10.1001/jamanetworkopen.2023.43796
     [Google Scholar]
  3. Star J, Bandi P, Siegel RL, Han X, Minihan A, Smith RA, et al.. Cancer screening in the United States during the second year of the COVID-19 pandemic. J Clin Oncol. 2023 09; 41:(27):4352–9.https://doi.org/10.1200/JCO.22.02170
     [Google Scholar]
  4. Fedewa SA, Star J, Bandi P, Minihan A, Han X, Yabroff KR, et al.. Changes in cancer screening in the US during the COVID-19 pandemic. JAMA Netw Open. 2022 06; 5:(6):e2215490.https://doi.org/10.1001/jamanetworkopen.2022.15490
     [Google Scholar]
  5. Eijkelboom AH, de Munck L, Larsen M, Bijlsma MJ, Tjan-Heijnen VCG, van Gils CH, et al.. Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: a population-based study. Cancer Epidemiol. 2023 12; 87:102481.https://doi.org/10.1016/j.canep.2023.102481
     [Google Scholar]
  6. Nguyen DL, Ambinder EB, Myers KS, Oluyemi E. Addressing disparities related to access of multimodality breast imaging services before and during the COVID-19 pandemic. Acad Radiol. 2022 03; 29:(12):1852–60.https://doi.org/10.1016/j.acra.2022.03.017
     [Google Scholar]
  7. Cairns A, Jones VM, Cronin K, Yocobozzi M, Howard C, Lesko N, et al.. Impact of the COVID-19 pandemic on breast cancer screening and operative treatment. Am Surg. 2022 06; 88:(6):1051–3.https://doi.org/10.1177/00031348221087920
     [Google Scholar]
  8. Negrao EMS, Cabello C, Conz L, Mauad EC, Zeferino LC, Vale DB. The COVID-19 pandemic impact on breast cancer diagnosis: a retrospective study. Rev Bras Ginecol Obstet. 2022 09; 44:(9):871–7.https://doi.org/10.1055/s-0042-1749207
     [Google Scholar]
  9. Voigtländer S, Hakimhashemi A, Grundmann N, Radespiel-Tröger M, Inwald EC, Ortmann O, et al.. Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany. J Cancer Res Clin Oncol. 2023 08; 149:(10):7493–503.https://doi.org/10.1007/s00432-023-04707-0
     [Google Scholar]
  10. Guével E, Priou S, Lamé G, Wassermann J, Bey R, Uzan C, et al.. Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: a retrospective multicenter cohort study. Cancer Med. 2023 11; 12:(22):20918–29.https://doi.org/10.1002/cam4.6637
     [Google Scholar]
  11. Eijkelboom AH, de Munck L, Lobbes MBI, van Gils CH, Wesseling J, Westenend PJ, et al.. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic. Prev Med. 2021 10; 151:106602.https://doi.org/10.1016/j.ypmed.2021.106602
     [Google Scholar]
  12. General Assembly of the World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014 Summer; 81:(3):14–18.
     [Google Scholar]
  13. Romaszko-Wojtowicz A, Tokarczyk-Malesa K, Doboszyńska A, Glińska-Lewczuk K. Impact of COVID-19 on antibiotic usage in primary care: a retrospective analysis. Sci Rep. 2024 02; 14:(1):4798.https://doi.org/10.1038/s41598-024-55540-5
     [Google Scholar]
  14. Lombardi A, Vitale V, Nigri G, Olivieri C, Mastrangeli MR, Bizzaglia E, et al.. Prognostic impact of the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system on clinically negative lymph nodes (cN0) breast cancer patients. Breast J. 2020 07; 26:(7):1265–9.https://doi.org/10.1111/tbj.13807
     [Google Scholar]
  15. Didkowska J, Wojciechowska U, Michalek IM, Caetano dos Santos FL. Cancer incidence and mortality in Poland in 2019. Sci Rep. 2022 06; 12:(1):10875.https://doi.org/10.1038/s41598-022-14779-6
     [Google Scholar]
  16. DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Sauer AG, et al.. Breast cancer statistics, 2019. CA Cancer J Clin. 2019 11; 69:(6):438–51.https://doi.org/10.3322/caac.21583
     [Google Scholar]
  17. Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncol. 2016 09-10; 55:(9–10):1158–60.https://doi.org/10.1080/0284186X.2016.1197419
     [Google Scholar]
  18. Gawrych M, Cichoń E, Kiejna A. COVID-19 pandemic fear, life satisfaction and mental health at the initial stage of the pandemic in the largest cities in Poland. Psychol Health Med. 2021 01; 26:(1):107–13.https://doi.org/10.1080/13548506.2020.1861314
     [Google Scholar]
  19. Resende CAA, Fernandes Cruz HM, Costa E Silva M, Paes RD, Dienstmann R, Barrios CHE, et al.. Impact of the COVID-19 pandemic on cancer staging: an analysis of patients with breast cancer from a community practice in Brazil. JCO Glob Oncol. 2022 11; 8:e2200289.https://doi.org/10.1200/GO.22.00289
     [Google Scholar]
  20. Li T, Nickel B, Ngo P, McFadden K, Brennan M, Marinovich ML, et al.. A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis. Breast. 2023 02 67:78.https://doi.org/10.1016/j.breast.2023.01.001
     [Google Scholar]
  21. Lucas E, Murillo R, Arrossi S, Bárcena M, Chami Y, Nessa A, et al.. Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand. eLife. 2023 05; 12:e86527.https://doi.org/10.7554/eLife.86527
     [Google Scholar]
  22. Chiu HM, Su CW, Hsu WF, Jen GHH, Hsu CY, Chen SLS, et al.. Mitigating the impact of COVID-19 on colorectal cancer screening: organized service screening perspectives from the Asia-Pacific region. Prev Med. 2021 10; 151:106622.https://doi.org/10.1016/j.ypmed.2021.106622
     [Google Scholar]
  23. Koczkodaj P, Kamiński MF, Ciuba A, Didkowska J. Cancer screening coverage in Poland – From bad to better to the worst during the SARS-CoV-2 pandemic. Arch Med Sci. 2021 04; 17:(4):1132–133.https://doi.org/10.5114/aoms/134239
     [Google Scholar]
  24. Lee K, Lee YY, Suh M, Jun JK, Park B, Kim Y, et al.. Impact of COVID-19 on cancer screening in South Korea. Sci Rep. 2022 06; 12:11380.https://doi.org/10.1038/s41598-022-15778-3
     [Google Scholar]
  25. Mendes D, Figueiredo D, Alves C, Penedones A, Costa B, Marques FB. P10 impact of the COVID-19 pandemic on cancer screenings in Portugal and years of life lost due to delayed diagnoses. Value Health. 2023 12; 26:(12):S2–S3.https://doi.org/10.1016/j.jval.2023.09.012
     [Google Scholar]
  26. Grimm LJ, Lee C, Rosenberg RD, Burleson J, Simanowith M, Fruscello T, et al.. Impact of the COVID-19 pandemic on breast imaging: an analysis of the national mammography database. J Am Coll Radiol. 2022 08; 19:(8):919–34.https://doi.org/10.1016/j.jacr.2022.04.008
     [Google Scholar]
  27. da Cunha AR, Antunes JLF. Impact of the COVID-19 pandemic on cancer mortality in Brazil. BMC Cancer. 2024 09; 24:(1):1125.https://doi.org/10.1186/s12885-024-12761-1
     [Google Scholar]
  28. Alagoz O, Lowry KP, Kurian AW, Mandelblatt JS, Ergun MA, Huang H, et al.. Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling. J Natl Cancer Inst. 2021 11; 113:(11):1484–94.https://doi.org/10.1093/jnci/djab097
     [Google Scholar]
  29. Chung SH, Romatoski KS, Rasic G, Beaulieu-Jones BR, Kelly Kenzik K, Merrill AL, et al.. Impact of the COVID-19 pandemic on delays to breast cancer surgery: ripples or waves? Ann Surg Oncol. 2023 10 30:6093.https://doi.org/10.1245/s10434-023-13878-6
     [Google Scholar]
  30. Trifanescu OG, Gales L, Bacinschi X, Serbanescu L, Georgescu M, Sandu A, et al.. Impact of the COVID-19 pandemic on treatment and oncologic outcomes for cancer patients in Romania. In Vivo. 2022 03-04; 36:(2):934–41.https://doi.org/10.21873/invivo.12783
     [Google Scholar]
/content/journals/10.5339/qmj.2025.85
Loading
The impact of the COVID-19 Pandemic on breast cancer incidence and stage: Results of a retrospective study
Qatar Medical Journal 2025, 85 (2025); https://doi.org/10.5339/qmj.2025.85
/content/journals/10.5339/qmj.2025.85
/content/journals/10.5339/qmj.2025.85
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): age groups, Breast cancer, delayed diagnosis, mammography, preventive examination, quarantine restrictions and radiation therapy

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error